Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$88.8m reported value -14.3% vs Q2 2024
13positions
89.3%in top 10
0 new 5 added 5 reduced 0 sold out vs Q2 2024

Options: 0 call positions (— notional), 1 put positions ($43.0m notional) – listed below, not included above.

Holdings, Q3 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 795,813 $15.4m17.35% 17.35% ReducedShares held: Q4 2023 908.5k, Q1 2024 908.5k, Q2 2024 908.5k, Q3 2024 795.8k -112.7k -112,661 -12.4%
2 BLUEPRINT MEDICINES CORP COM BPMC BPMC 124,600 $11.5m12.97% 12.97% AddedShares held: Q4 2023 254.8k, Q1 2024 182.2k, Q2 2024 114.6k, Q3 2024 124.6k +10.0k +10,000 8.7%
3 KYMERA THERAPEUTICS INC COM KYMR KYMR 208,743 $9.9m11.12% 11.12% ReducedShares held: Q4 2023 881.3k, Q1 2024 388.7k, Q2 2024 328.7k, Q3 2024 208.7k -120.0k -120,000 -36.5%
4 REGENXBIO INC COM RGNX RGNX 930,708 $9.8m10.99% 10.99% AddedShares held: Q4 2023 802.4k, Q1 2024 906.2k, Q2 2024 906.2k, Q3 2024 930.7k +24.5k +24,460 2.7%
5 ARVINAS INC COM ARVN ARVN 388,766 $9.6m10.78% 10.78% ReducedShares held: Q4 2023 489.2k, Q1 2024 405.8k, Q2 2024 428.8k, Q3 2024 388.8k -40.0k -40,000 -9.3%
6 MERUS N V COM MRUS MRUS 117,855 $5.9m6.63% 6.63% ReducedShares held: Q4 2023 355.1k, Q1 2024 255.1k, Q2 2024 148.1k, Q3 2024 117.9k -30.3k -30,254 -20.4%
7 SILENCE THERAPEUTICS PLC ADS SLN SLN 317,214 $5.8m6.49% 6.49% ReducedShares held: Q4 2023 1.0m, Q1 2024 574.2k, Q2 2024 500.2k, Q3 2024 317.2k -183.0k -183,000 -36.6%
8 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 181,911 $4.1m4.63% 4.63% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 156.7k, Q3 2024 181.9k +25.2k +25,219 16.1%
9 IMMATICS N.V SHS IMTX IMTX 333,502 $3.8m4.28% 4.28% AddedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 200.0k, Q3 2024 333.5k +133.5k +133,502 66.8%
10 ADICET BIO INC COM COM 2,531,194 $3.6m4.10% 4.10% UnchangedShares held: Q4 2023 0, Q1 2024 0, Q2 2024 2.5m, Q3 2024 2.5m
11 PRECISION BIOSCIENCES INC COM NEW DTIL DTIL 381,803 $3.4m3.85% 3.85% UnchangedShares held: Q4 2023 0, Q1 2024 385.4k, Q2 2024 381.8k, Q3 2024 381.8k
12 REPARE THERAPEUTICS INC COM RPTX RPTX 989,364 $3.4m3.83% 3.83% AddedShares held: Q4 2023 633.3k, Q1 2024 633.3k, Q2 2024 956.9k, Q3 2024 989.4k +32.4k +32,432 3.4%
13 SUTRO BIOPHARMA INC COM COM 762,498 $2.6m2.97% 2.97% UnchangedShares held: Q4 2023 420.6k, Q1 2024 1.2m, Q2 2024 762.5k, Q3 2024 762.5k

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 75,000 $43.0m75.0k shares New